SCHEMBL8472797

SCHEMBL8472797

C[SiH](C)OC(COc1cccc(N)c1)C(C)(C)C

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 2/20 0.49
▸ TP53 P04637 1/20 0.49
▸ TSHR P16473 2/20 0.43
▸ MAOB P27338 2/20 0.42
▸ ALDH1A1 P00352 1/20 0.41
▸ APP P05067 1/20 0.39
▸ POLB P06746 1/20 0.36
▸ HSP90AA1 P07900 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ MAPK1 P28482 1/20 0.33
▸ HIF1A Q16665 1/20 0.33
▸ CASR P41180 1/20 0.33
▸ ADRB2 P07550 1/20 0.32
▸ ADRB1 P08588 1/20 0.32
▸ ADRB3 P13945 1/20 0.32
▸ LTA4H P09960 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8476668 0.86 TSHR (0.48) CYP3A4TP53TSHRMAOBALDH1A1
SCHEMBL6617442 0.79 CHRM2 (0.34) TSHRMAPK1
SCHEMBL8472554 0.78 CHRNB2 (0.49) TSHRMAOBALDH1A1POLBMAPT
SCHEMBL112113 0.73 CYP3A4 (0.63) CYP3A4TP53TSHRMAOBALDH1A1
SCHEMBL8472790 0.71 CYP3A4 (0.41) CYP3A4TP53TSHRMAOBALDH1A1
SCHEMBL4958479 0.70 CYP3A4 (0.59) CYP3A4TP53TSHRMAOBALDH1A1
SCHEMBL27669995 0.70 CYP3A4 (0.65) CYP3A4TP53TSHRMAOBALDH1A1
SCHEMBL10635987 0.70 LMNA (0.61) CYP3A4TP53TSHRMAOBALDH1A1
SCHEMBL3544164 0.70 CYP3A4 (0.59) CYP3A4TP53TSHRMAOBALDH1A1
SCHEMBL14497405 0.70 CYP3A4 (0.54) CYP3A4TP53TSHRMAOBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5972937-A Heterocyclic compounds possessing 5HT2C receptor antagonist activity SMITHKLINE BEECHAM P.L.C. (GB) 1999-10-26 — — US disclosed
EP-0807104-A2 HETEROCYCLIC COMPOUNDS POSSESSING 5HT 2C? RECEPTOR ANTAGONIST ACTIVITY SMITHKLINE BEECHAM PLC (GB) 1997-11-19 — — EP disclosed
WO-1996023769-A2 HETEROCYCLIC COMPOUNDS POSSESSING 5HT2C RECEPTOR ANTAGONIST ACTIVITY SMITHKLINE BEECHAM PLC (GB) 1996-08-08 — — WO disclosed
Send feedback